Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mixed Phase 3 Trials For Omeros Treatment Sinks Stock
Barron's
Saturday, December 29, 2012 - 9:45am
tags:
Omeros, OMS103HP, arthroscopic
Emergent BioSolutions Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate
Yahoo/BusinessWire
Saturday, December 29, 2012 - 9:43am
tags:
Emergent BioSolutions, flu vaccines, vaccines
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Investopedia
Saturday, December 29, 2012 - 9:42am
tags:
Celgene Corporation, Regeneron, Gilead Sciences
FDA clears anticlotting drug Eliquis
Yahoo/AP
Friday, December 28, 2012 - 9:28pm
tags:
FDA, Eliquis, Pfizer, Bristol-Myers Squibb
Takeda writes off its $1B obesity deal with Amylin
Fierce Biotech
Friday, December 28, 2012 - 11:59am
tags:
Amylin, Takeda
Perrigo nails down dermatology spot with $45M deal
Fierce Pharma
Friday, December 28, 2012 - 11:57am
tags:
Perrigo, dermatology, M&A, Cobrek Pharmaceuticals
Cellceutix Is Due For A Hard Correction
Seeking Alpha
Friday, December 28, 2012 - 11:54am
tags:
Cellceutix
A Triple Play Of Biotech Disappointments Last Week
Investopedia
Friday, December 28, 2012 - 11:45am
tags:
Amicus, Hemispherx Biopharma, GSK, Oncothyreon
Aeterna Zentaris soars on U.S. FDA trial agreement
Reuters
Friday, December 28, 2012 - 11:43am
tags:
Aeterna Zentaris, AEZS-108, endometrial cancer
2 BioPharma Stocks To Consider: Data & Facts
Motley Fool
Friday, December 28, 2012 - 11:41am
tags:
Abbott Labs, Gilead, Eli Lilly
Arena Wins!
Seeking Alpha
Friday, December 28, 2012 - 11:38am
tags:
Arena Pharmaceuticals, Orexigen, Vivus, Belviq, Contrave, Qsymia
2012 Roundup -- HCV Treatments
Motley Fool
Friday, December 28, 2012 - 11:36am
tags:
hepatitis C, Vertex Pharmaceuticals, Gilead, Merck, Abbott Labs, Achillion, GSK, JNJ, Idenix, Bristol-Myers Squibb
Will FDA Grant Accelerated Approval To J&J TB Drug?
Pharmalot
Friday, December 28, 2012 - 11:33am
tags:
FDA, JNJ, tuberculosis, bedaquiline
Pfizer Playing the Right Card Amid Changing Sector Landscape
Motley Fool
Friday, December 28, 2012 - 11:31am
tags:
Pfizer, Merck, JNJ
Watson challenges patent on cancer drug Velcade
Yahoo/AP
Friday, December 28, 2012 - 11:29am
tags:
Watson Pharmaceuticals, Velcade, Millennium, Multiple Myeloma
AbbVie Wants To Be Hunter, Not Hunted Post-Abbott Split
Forbes
Friday, December 28, 2012 - 11:28am
tags:
AbbVie
Do the Interactions of Pharma With Medical Experts Compromise Health Guidelines?
Forbes
Friday, December 28, 2012 - 11:28am
tags:
R&D
Raptor Drug FDA Action Date Delayed
Yahoo/Zacks
Friday, December 28, 2012 - 11:26am
tags:
FDA, Raptor Pharmaceuticals, procysbi, nephropathic cystinosis
This Biotech Is Opportunistic With Recent CEO Buys
Motley Fool
Thursday, December 27, 2012 - 11:15pm
tags:
United Therapeutics
DEA Scheduling Helps Arena
Motley Fool
Thursday, December 27, 2012 - 10:57pm
tags:
DEA, Arena Pharmaceuticals, Belviq

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.